GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CBD Life Sciences Inc (OTCPK:CBDL) » Definitions » COGS-to-Revenue

CBD Life Sciences (CBD Life Sciences) COGS-to-Revenue : 0.00 (As of Sep. 2015)


View and export this data going back to 2009. Start your Free Trial

What is CBD Life Sciences COGS-to-Revenue?

CBD Life Sciences's Cost of Goods Sold for the three months ended in Sep. 2015 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2015 was $0.00 Mil.

CBD Life Sciences's COGS to Revenue for the three months ended in Sep. 2015 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. CBD Life Sciences's Gross Margin % for the three months ended in Sep. 2015 was N/A%.


CBD Life Sciences COGS-to-Revenue Historical Data

The historical data trend for CBD Life Sciences's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CBD Life Sciences COGS-to-Revenue Chart

CBD Life Sciences Annual Data
Trend Dec11 Dec12 Dec13 Dec14
COGS-to-Revenue
- - - -

CBD Life Sciences Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CBD Life Sciences COGS-to-Revenue Calculation

CBD Life Sciences's COGS to Revenue for the fiscal year that ended in Dec. 2014 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0.123
=0.00

CBD Life Sciences's COGS to Revenue for the quarter that ended in Sep. 2015 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CBD Life Sciences  (OTCPK:CBDL) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

CBD Life Sciences's Gross Margin % for the three months ended in Sep. 2015 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


CBD Life Sciences COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of CBD Life Sciences's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CBD Life Sciences (CBD Life Sciences) Business Description

Traded in Other Exchanges
N/A
Address
10853 N. Frank Llyod Wright Boulevard, Suite 108, Scottsdale, AZ, USA, 85259
CBD Life Sciences Inc is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products. The company is also in the process of developing an anti-aging skin product line.